We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Safety monitoring and information (121)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
572 result(s) found, displaying 176 to 200
-
Safety alertsSafety advisory - diabetic ketoacidosis and surgical procedures
-
-
Safety alertsMeltz Instant Energy For Males tablets pose a serious risk to your health and should not be taken.
-
Safety alertsBulbao Male Enhancer tablets pose a serious risk to your health and should not be taken
-
Safety alertsPlatinum - Male Enhancer capsules pose a serious risk to your health and should not be taken.
-
Market actionsProduct defect alert - potential for blister strip to contain lower strength tablets
-
-
-
-
Safety alertsInformation about influenza vaccines for use in 2018
-
Safety alertsLida (Plus) capsules pose a serious risk to your health and should not be taken
-
Safety alertsSlim Trim Gold capsules pose a serious risk to your health and should not be taken
-
Market actionsRecall - risk of injury due to potential contamination with plastic fragment
-
Safety alertsSLAM Natural Formula 29000 mg capsules pose a serious risk to your health and should not be taken
-
Safety alertsThis review concerns the safety of use of codeine-containing products in children in the context of ultra-rapid metabolisers
-
Safety alertsSafety Alert - Maximum Powerful (Baiwei USA) tablets
-
-
Market actionsRecall - may pose a serious health hazard to children
-
-
Market actionsRecall – potential for allergic reactions due to higher than expected amounts of histamine
-
Market actionsRecall – potential for incomplete delivery of medication
-
Safety alertsThe TGA cancelled all medical devices manufactured by Silimed from the Australian Register of Therapeutic Goods on 5 November 2016
-
-
-